Citations

Showing 10 of 108094 citations.

Review of the Diagnosis and Management of Lumbar Spinal Stenosis
Orhurhu, Vwaire , Hussain, Nasir , D’Souza, Ryan S. , D'Souza, Ryan, D'Souza, Ryan S

Mayo Clinic

JAMA | August 23, 2022 | Volume: 328 | Issue: 8 | Pages: 779

10.1001/jama.2022.11378 | PMID 35997741 Get It

A 20-Year-Old Woman with Fever and Right Upper Quadrant Abdominal Pain
Voth, Elida , Colbenson, Gretchen A. , Sanborn, D. M. , Colbenson, Gretchen, SANBORN, DAVID, Olson, Emily M. , Sanborn, David

Mayo Clinic

NEJM Evidence | August 23, 2022 | Volume: 1 | Issue: 9 | Pages: No page available

10.1056/evidmr2200170 | PMID 38319806 Get It

Soluble urinary somatic angiotensin converting enzyme is overexpressed in patients with preeclampsia: a potential new marker for the disease?
Sontag, Fernando , Šuvakov, Sonja , Garovic, Vesna D.

Mayo Clinic

Hypertension in Pregnancy | August 23, 2022 | Volume: 41 | Issue: 3-4 | Pages: 190-197

10.1080/10641955.2022.2115060 | PMID 35997304 Get It

Role of Obesity-Induced Inflammatory Cytokines on Breast Cancer & Therapeutics
Joty, Moshaffayata Jarin, Afroz, Sabrina, Deactivated, Given Names Deactivated Family Name , Towhid, Saiful, Rahman, Mustafijur, Rajia, Sultana , Ghosh, Ammy Shankar , Joty, Moshaffayata Jarin, Khan, Salma , Afroz, Dr. Sabrina

Mayo Clinic

No container title available | August 23, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.14293/s2199-1006.1.sor-.ppuyvei.v1 Get It

According to WHO, obesity, a global pandemic, is an important cause of cancer. Obesity-induced adipose tissue expansion is associated with infiltration of immune cells which causessecretion of adipokines, chemokines, cytokines like IL-1,2,6,8, TNF-α, etc. The purpose of thisstudy is to provide a comprehensive review of the effects of obesity-induced inflammatorycytokines on breast cancer while discussing available therapeutics & chemotherapy in thetreatment of breast cancer. We discussed the identification of inflammatory biomarkers releasedby adipose tissue, and alterations in their pathway in the pathogenesis of breast cancer. Our studyhelps in improving diagnostic accuracy, identifying targets of therapy, and suggesting usefullifestyle behaviors for this aspect. We conducted our research in PubMed to identify relevantjournal articles published within the last 10 years. We extracted pertinent data and discussedmajor signaling pathways regulated by inflammatory cytokines and adipokines in mediatingbreast cancer. Obesity involves different changes that may contribute to the development ofbreast cancer, such as excess inflammatory cytokines and chronic inflammation,hyperinsulinemia, insulin resistance, and raised leptin and estrogens. It leads to a low-gradechronic inflammatory state in the body, which leads to increased estrogen and aromatase,increased growth proliferation, and angiogenesis. All of these contribute to the development ofbreast cancer, mostly ductal breast cancer and ER-positive breast cancer. Leptin antagonist,Adiponectin agonists, aromatase inhibitors, and lipid-lowering drugs have shown favorable resultsin the treatment of breast cancer. Metformin inhibits the IL-6 mRNA expression and activatesthe IL-1R expression which acts as an anti-inflammatory cytokine. In breast cancer cells,Metformin interferes with mTOR pathway signaling and decreases the expression of HER-2protein. Weight loss with exercise and reduced calorie intake reduces the risk of breast cancer inboth premenopausal and postmenopausal women. Early detection using “biomarkers” shows apromising improvement in the survival rate.
Geographic Distribution of Otolaryngology Training Programs and Potential Opportunities for Strategic Program Growth
Smith, Drew H. , Case, Hannah F., Quereshy, Humzah A. , Mecham, Jeffrey C. , Bowe, Sarah N. , Carlson, Matthew L. , Cordero, Joehassin , Case, Hannah , Bowe, Sarah N

Mayo Clinic

The Laryngoscope | August 23, 2022 | Volume: 133 | Issue: 7 | Pages: 1600-1605

10.1002/lary.30361 | PMID 36054023 Get It

ObjectiveTo characterize the geographic distribution of US otolaryngology residents based on geographical population density to determine current status and identify potential opportunities for otolaryngology residency program expansion.MethodsThe locoregional population of otolaryngology residency programs was analyzed (as defined by the US Census) and the number of resident trainees per 100,000 people in each region was calculated. Otolaryngology residency program location was determined by mailing address, and program size was determined by AAMC public data.ResultsThe average metropolitan city in the United States contained 2.07 otolaryngology trainees per 100,000 people. Cities with low trainee numbers per population included Phoenix, AZ (0.20 trainees per 100,000 people); Las Vegas, NV (0.26 per 100,000); Dallas, TX (0.26 per 100,000), Atlanta, GA (0.33 per 100,000); and Miami, FL (0.34 per 100,000). Comparing otolaryngology to other surgical subspecialties demonstrated similar distributions. Metropolitan centers with a population over 1 million without full academic representation in otolaryngology were also identified and included Charlotte, NC; Orlando, FL; Austin, TX; Providence, RI; Jacksonville, FL; Raleigh, NC; and Grand Rapids, MI.ConclusionStrategic residency training program expansion should be considered in cities that exhibit a low trainee to population ratio. Although many factors ultimately determine program expansion or development of new training programs, this study provides substantiated population data describing where expansion could be prioritized.Level of EvidenceNA Laryngoscope, 133:1600–1605, 2023
Common Variants Near ZIC1 and ZIC4 in Autopsy‐Confirmed Multiple System Atrophy
Hopfner, Franziska , Tietz, Anja, Ruf, Viktoria , Ross, Owen A. , Koga, Shunsuke , Attems, Johannes , Beach, Thomas, Beller, Allison , Duyckaerts, Charles, Evsyukov, Valentin, Flanagan, Margaret E. , Frosch, Matthew P. , Gearing, Marla , Gelpí, Ellen , Gerpen, Jay A. van, Glass, Jonathan D. , Grinberg, Lea T. , Halliday, Glenda M. , Höllerhage, Matthias , Huitinga, Inge , Keene, Dirk, Kovács, Gábor G. , Lee, Edward B. , Xiong, Chengjie , Martı́, Marı́a José , Mackenzie, Ian R. , Mollenhauer, Brit , Neumann, Manuela , Newell, Kathy L. , Pendziwiat, Manuela , Molina‐Porcel, Laura , Rábano, Alberto , Rajput, Alex, Rajput, Ali H. , Reimann, Regina , Selvackadunco, Sashika , Simuni, Tanya , Svenningsson, Per , Trenkwalder, Claudia , Troakes, Claire , Trojanowski, John Q. , Uitti, Ryan J. , Xie, Tao , Ximelis, Teresa , Yebenes, Justo, Müller, Ulrich , Schellenberg, Gerard D., Herms, Jochen , Kuhlenbäumer, Gregor , Deuschl, Günther , Gelpi, Ellen , Van Gerpen, Jay A, Halliday, Glenda , Irwin, David J , Mollenhauer, Brit , Pantelyat, Alex , Svenningsson, Per , Höglinger, Günter U , Koga, Shunsuke , Ross, Owen A , Kovacs, Gabor G , Xiong, Chengjie , Grinberg, Lea , Molina-Porcel, Laura , Troakes, Claire , Hopfner, Franziska , Lee, Edward B , Simuni, Tanya , Dickson, Dennis W. , Aguzzi, Adriano , Cheshire, William P. , Deerlin, Vivianna M. Van , Desplats, Paula , Deuschl, Günther , Duyckaerts, Charles , Ellinghaus, David , Franke, André , Ghetti, Bernardino , Helbig, Ingo , Irwin, David J. , McKeith, Ian G. , McLean, Catriona , Pantelyat, Alexander , Peters, Annette , Matěj, Radoslav , Scott, William K. , Seeley, William W. , Stadelmann, Christine , Thomas, Alan , White, Charles L. , Wszołek, Zbigniew K. , Schellenberg, Gerard D., Höglinger, Günter U. , Flanagan, Margaret E

Mayo Clinic

Movement Disorders | August 23, 2022 | Volume: 37 | Issue: 10 | Pages: 2110-2121

10.1002/mds.29164 | PMID 35997131 Get It

ABSTRACT Background Multiple System Atrophy is a rare neurodegenerative disease with alpha‐synuclein aggregation in glial cytoplasmic inclusions and either predominant olivopontocerebellar atrophy or striatonigral degeneration, leading to dysautonomia, parkinsonism, and cerebellar ataxia. One prior genome‐wide association study in mainly clinically diagnosed patients with Multiple System Atrophy failed to identify genetic variants predisposing for the disease. Objective Since the clinical diagnosis of Multiple System Atrophy yields a high rate of misdiagnosis when compared to the neuropathological gold standard, we studied only autopsy‐confirmed cases. Methods We studied common genetic variations in Multiple System Atrophy cases (N = 731) and controls (N = 2898). Results The most strongly disease‐associated markers were rs16859966 on chromosome 3, rs7013955 on chromosome 8, and rs116607983 on chromosome 4 with P ‐values below 5 × 10 −6 , all of which were supported by at least one additional genotyped and several imputed single nucleotide polymorphisms. The genes closest to the chromosome 3 locus are ZIC1 and ZIC4 encoding the zinc finger proteins of cerebellum 1 and 4 (ZIC1 and ZIC4). Interpretation Since mutations of ZIC1 and ZIC4 and paraneoplastic autoantibodies directed against ZIC4 are associated with severe cerebellar dysfunction, we conducted immunohistochemical analyses in brain tissue of the frontal cortex and the cerebellum from 24 Multiple System Atrophy patients. Strong immunohistochemical expression of ZIC4 was detected in a subset of neurons of the dentate nucleus in all healthy controls and in patients with striatonigral degeneration, whereas ZIC4‐immunoreactive neurons were significantly reduced inpatients with olivopontocerebellar atrophy. These findings point to a potential ZIC4‐mediated vulnerability of neurons in Multiple System Atrophy. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society
Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States
Singal, Amit G. , Lauzon, Marie , Luu, Michael , Noureddin, Mazen , Todo, Tsuyoshi , Kim, Irene , Friedman, Marc L., Kosari, Kambiz , Nissen, Nicholas N. , Roberts, Lewis R. , Yang, Ju Dong , Singal, Amit , Yang, Ju Dong , Roberts, Lewis R , Lee, Yi‐Te , Agopian, Vatche G. , Heimbach, Julie K. , Gores, Gregory J.

Mayo Clinic

Cancer | August 23, 2022 | Volume: 128 | Issue: 20 | Pages: 3610-3619

10.1002/cncr.34436 | PMID 35997126 Get It

BackgroundCurative surgical treatments afford the best prognosis for patients with intrahepatic cholangiocarcinoma (iCCA); however, the comparative effectiveness of treatment options and factors associated with curative treatment receipt for early stage iCCA remain unknown.MethodsThe authors identified patients who were diagnosed with early stage iCCA, defined as a unifocal tumor <3 cm, during 2004–2018 from the National Cancer Database. Multivariable logistic and Cox regression analyses were used to identify the factors associated with curative treatment and overall survival (OS), respectively.ResultsThe proportion of patients with early stage iCCA increased from 4.5% in 2004 to 7.3% in 2018, with the odds of early stage detection increasing by 3.1% per year (odds ratio [OR], 1.031; 95% CI, 1.015–1.049). Of 1093 patients who had early stage iCCA, 464 (42.5%) underwent resection, 113 (10.3%) underwent ablation, 62 (5.7%) underwent liver transplantation, and 454 (41.5%) received noncurative treatments. Hispanic patients (adjusted OR [aOR], 0.57; 95% CI, 0.33–0.97) and Black patients (aOR, 0.47; 95% CI, 0.28–0.77) were less likely to receive curative treatments than White patients. Compared with patients who underwent surgical resection, those who underwent liver transplantation had a trend toward improved OS (adjusted hazard ratio [aHR], 0.63; 95% CI, 0.37–1.08), whereas those who underwent local ablation (aHR, 1.39; 95% CI, 1.01–1.92) and noncurative treatments (aHR, 3.97; 95% CI, 3.24–4.88) experienced worse OS.ConclusionsMore than one third of patients with early stage iCCA did not receive curative treatment, with Hispanic and Black patients being less likely to receive curative treatments than White patients. Surgical resection and liver transplantation were associated with improved survival compared with local ablation. Future studies should investigate disparities in curative treatment receipt and outcomes for early stage iCCA.
Tyrosine kinase inhibitors dosing for chronic phase chronic myeloid leukemia: The case for starting low with dasatinib (50 mg/day) and ponatinib (15 mg/day)
Tefferi, Ayalew , Begna, Kebede H. , McCullough, Kristen , McCullough, Kristen B

Mayo Clinic

American Journal of Hematology | August 23, 2022 | Volume: 97 | Issue: 11 | Pages: 1394-1397

10.1002/ajh.26695 | PMID 35996356 Get It

Radiomics and Artificial Intelligence in Predicting Axillary Lymph Node Metastasis in Breast Cancer: A Systematic Review
Eldaly, Abdullah S. , Maita, Karla C. , Serrano, Luiza Palmieri , Forte, Antonio J. , Torres-Guzman, Ricardo A, Maita, Karla , Forte, Antonio Jorge , Eldaly, Abdullah , Ávila, Francisco R. , Torres‐Guzman, Ricardo A. , Garcia, John P.

Mayo Clinic

Current Medical Imaging Formerly Current Medical Imaging Reviews | August 23, 2022 | Volume: 19 | Issue: 6 | Pages: No page available

10.2174/1573405618666220822093226 | PMID 35996255 Get It

Background: Breast cancer is the most common malignancy and the second most common cause of death in women worldwide. Axillary lymph node metastasis (ALNM) is the most significant prognostic factor in breast cancer. Under the current guidelines, sentinel lymph node biopsy (SLNB) is the standard of axillary staging in patients with clinically-node negative breast cancer. Despite the minimally invasive nature of SLNB, it can cause short and long-term morbidities including pain, sensory impairment, and upper limb motor dysfunction. However, lymphedema remains the most feared adverse event, and it affects 7% of patients within 36 months of follow-up. Recently, we have witnessed the implication of radiomics and artificial intelligence domains in the diagnosis and follow-up of many malignancies with promising results. Therefore, we have conducted a systematic search to investigate the potentials of radiomics and artificial intelligence in predicting ALNM. Methods: Four electronic databases were searched: PubMed, Scopus, CINAHL, and Web of Science. We used the Preferred Reporting Items for Systematic Reviews and Meta-Analysis as our basis of organization. Results: For radiomics, area under the curve (AUC) for the included studies ranged from 0.715 to 0.93. Accuracy ranged from 67.7% to 98%. Sensitivity and specificity ranged from 70.3% to 97.8% and 58.4% to 98.2%, respectively. For other artificial intelligence methods, AUC ranged from 0.68 to 0.98, while accuracy ranged from 55% to 89%. Conclusion: The results of radiomics and artificial intelligence in predicting ALNM are promising. However, validation as a substitute to SLNB requires more substantial evidence from large randomized trials.
Editorial: potassium‐competitive acid blockers—is there a role for more complete acid suppression?
DeVault, Kenneth R.

Mayo Clinic

Alimentary Pharmacology & Therapeutics | August 23, 2022 | Volume: 56 | Issue: 6 | Pages: 1071-1071

10.1111/apt.17127 | PMID 35995736 Get It

LINKED CONTENTThis article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.16959 and https://doi.org/10.1111/apt.17176